Answer
Tepotinib inhibits both hepatocyte growth factor (HGF)-dependent and HGF-independent MET phosphorylation and MET-dependent downstream signalling pathways.
Sources for this answer
- Tepotinib 225 mg film-coated tabletsMerck · emc · SmPC §5.1 Pharmacodynamic properties · Version 2Document updated
Sources checked